SCHEMBL9865565

SCHEMBL9865565

O=C(NC(=NCC(O)COc1ccccc1)NCCCc1c[nH]cn1)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 5/20 0.38
ADRB3 P13945 5/20 0.38
RAB9A P51151 3/20 0.35
NPC1 O15118 2/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ADRB2 P07550 3/20 0.35
SCN5A Q14524 3/20 0.35
SCN2A Q99250 2/20 0.35
HRH3 Q9Y5N1 2/20 0.33
POLB P06746 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
HRH2 P25021 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
SCN1A P35498 1/20 0.33
SCN9A Q15858 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9866314 0.86 KDM4E (0.43)
SCHEMBL9865576 0.86 ADRB1 (0.40) ADRB1ADRB3ADRB2SCN5ASCN2A
SCHEMBL9865552 0.86 ADRB1 (0.40) ADRB1ADRB3ADRB2SCN5ASCN2A
SCHEMBL9865894 0.85 SCN5A (0.45) RAB9ANPC1HPGDSMN1; SMN2SCN5A
SCHEMBL9865122 0.85 SCN5A (0.44) RAB9ANPC1HPGDSMN1; SMN2SCN5A
SCHEMBL9865887 0.85 SCN5A (0.45) RAB9ANPC1HPGDSMN1; SMN2SCN5A
SCHEMBL9865114 0.85 SCN5A (0.44) RAB9ANPC1HPGDSMN1; SMN2SCN5A
SCHEMBL9867300 0.85 POLB (0.38) ADRB1ADRB3RAB9ANPC1HPGD
SCHEMBL9867294 0.85 POLB (0.38) ADRB1ADRB3RAB9ANPC1HPGD
SCHEMBL9865905 0.83 NPC1 (0.46) RAB9ANPC1HPGDSMN1; SMN2SCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5021431-A H-1 antagonist, h-2 agonist for treating hypertension, cardiac disease or arterial occlusion HEUMANN PHARMA GMBH & CO. (DE) 1991-06-04 US disclosed
EP-0199845-B1 IMIDAZOLYLALKYLGUANIDIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM HEUMANN PHARMA GMBH & CO (DE) 1990-08-01 EP disclosed
EP-0199845-A1 Imidazolylalkylguanidin derivatives, process for their preparation and pharmaceutical compositions containing them HEUMANN PHARMA GMBH & CO (DE) 1986-11-05 EP disclosed